Detalles de la búsqueda
1.
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
Rheumatology (Oxford)
; 62(6): 2122-2129, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36282537
2.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Ann Rheum Dis
; 81(3): 351-358, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34815219
3.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.
Ann Rheum Dis
; 81(2): 225-231, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911706
4.
Quantitative Proteomic Analyses of Molecular Mechanisms Associated with Cytoplasmic Incompatibility in Drosophila melanogaster Induced by Wolbachia.
J Proteome Res
; 14(9): 3835-47, 2015 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26220534
5.
Risk factors associated with efficacy outcomes in kidney transplantation: analysis of a contemporary cohort of patients from the A2309 trial.
Clin Nephrol
; 83(6): 338-44, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25816807
6.
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
Clin Transplant
; 27(2): 217-26, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23230975
7.
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.
RMD Open
; 8(2)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701011
8.
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial.
Lancet Rheumatol
; 4(6): e395-e406, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38293957
9.
Heritable clustering and pathway discovery in breast cancer integrating epigenetic and phenotypic data.
BMC Bioinformatics
; 8: 38, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17270052
10.
Prognostic DNA methylation biomarkers in ovarian cancer.
Clin Cancer Res
; 12(9): 2788-94, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16675572
11.
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Arthritis Care Res (Hoboken)
; 69(3): 347-355, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27696786
12.
Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.
Transplantation
; 101(10): 2612-2620, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333860
13.
Microarray analysis of gene expression: considerations in data mining and statistical treatment.
Physiol Genomics
; 25(3): 355-63, 2006 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-16554544
14.
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.
Clin Cancer Res
; 11(20): 7376-83, 2005 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16243810
15.
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
J Rheumatol
; 43(9): 1713-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27307536
16.
Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial.
J Nephrol
; 28(5): 633-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25708913
17.
Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
Transplantation
; 95(7): 933-42, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23422495
18.
Serial analysis of gene expression profiles of adult and aged mouse cerebellum.
Neurobiol Aging
; 29(5): 774-88, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17267076
19.
Modeling and analysis of multi-library, multi-group SAGE data with application to a study of mouse cerebellum.
Biometrics
; 63(3): 777-86, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17825009
Resultados
1 -
19
de 19
1
Próxima >
>>